Zuli Wang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
Papers in
-
- RNA modifications and cancer 10
- Epigenetics and DNA Methylation 8
- Cancer-related gene regulation 3
-
- Ferroptosis and cancer prognosis 9
- Co-authors
- Yongguang Tao (16 shared papers)Desheng Xiao (12 shared papers)Lianlian Ouyang (7 shared papers)Ying Shi (6 shared papers)Yating Liu (5 shared papers)Na Liu (3 shared papers)Samantha Tam (1 shared paper)Feiqiu Wen (1 shared paper)
- Journals
- Signal Transduction and Targeted Therapy (4 papers)The Journal of Organic Chemistry (2 papers)Oncogene (2 papers)Molecular Therapy (1 paper)Chemical Communications (1 paper)
- Partner nations
- ChinaSaudi ArabiaPoland
In The Last Decade
Zuli Wang
22 papers receiving 580 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 299
- Pulmonary and Respiratory Medicine 308
- Molecular Biology 429
- Immunology 48
- Oncology 60
Countries citing papers authored by Zuli Wang
This map shows the geographic impact of Zuli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuli Wang more than expected).
Fields of papers citing papers by Zuli Wang
This network shows the impact of papers produced by Zuli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuli Wang. The network helps show where Zuli Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zuli Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 203 | |
| 2 | 2020 | 66 | |
| 3 | 2022 | 47 | |
| 4 | 2023 | 39 | |
| 5 | 2023 | 33 | |
| 6 | 2023 | 29 | |
| 7 | 2023 | 24 | |
| 8 | 2020 | 24 | |
| 9 | 2023 | 22 | |
| 10 | 2019 | 22 | |
| 11 | 2023 | 21 | |
| 12 | 2021 | 16 | |
| 13 | 2025 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2023 | 7 | |
| 16 | 2019 | 4 | |
| 17 | 2025 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2023 | 1 |
About Zuli Wang
Zuli Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Organic Chemistry and Oncology, having authored 26 papers that have together received 581 indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Ferroptosis and cancer prognosis (9 papers), Epigenetics and DNA Methylation (8 papers), Cancer-related molecular mechanisms research (6 papers), Radical Photochemical Reactions (3 papers), Cancer-related gene regulation (3 papers), Synthesis of heterocyclic compounds (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (299 citations), Pulmonary and Respiratory Medicine (308 citations), Molecular Biology (429 citations), Immunology (48 citations) and Oncology (60 citations). Zuli Wang has collaborated with scholars based in China, Saudi Arabia and Poland. Frequent co-authors include Yongguang Tao, Desheng Xiao, Lianlian Ouyang, Ying Shi, Yating Liu, Na Liu, Samantha Tam, Feiqiu Wen, Xiaowen Chen and Shuang Liu. Their work appears in journals such as Signal Transduction and Targeted Therapy, The Journal of Organic Chemistry, Oncogene, Molecular Therapy and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.